Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients
- Author
- SCIACCA, F. L1 ; FERRI, C1 ; MARTINELLI, V4 ; COMI, G4 ; CANAL, N4 ; GRIMALDI, L. M. E1 ; VANDENBROECK, K2 ; VEGLIA, F3 ; GOBBI, C3 ; MARTINELLI, F4 ; FRANCIOTTA, D5 ; ZAFFARONI, M6 ; MARROSU, M7 ; MARTINO, G8
[1] Neuroimmunology Unit, San Raffaele Scientific Institute, Milan, Italy
[2] Rega Institute, Leuven, Belgium
[3] Biostatistics Unit, San Raffaele Scientific Institute, Milan, Italy
[4] Multiple Sclerosis Center, San Raffaele Scientific Institute, Milan, Italy
[5] Laboratory of Neuroimmunology, IRCCS C. Mondino Neurological Institute, Pavia, Italy
[6] Centro Sclerosi Multipla, Ospedale di Gallarate, Varese, Italy
[7] Istituto di Neuropsichiatria Infantile, University of Cagliari, Italy
[8] Experimental Neuroimmunotherapy Unit, San Raffaele Scientific Institute, Milan, Italy - Source
Neurology. 1999, Vol 52, Num 9, pp 1896-1898 ; ref : 10 ref
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antagoniste Exploration Homme Interleukine 1 Polymorphisme Récepteur Sclérose en plaque Cytokine Maladie inflammatoire Système nerveux central pathologie Système nerveux pathologie
- Keyword (en)
- Antagonist Exploration Human Interleukin 1 Polymorphism Receiver Multiple sclerosis Cytokine Inflammatory disease Central nervous system disease Nervous system diseases
- Keyword (es)
- Antagonista Exploración Hombre Interleuquina 1 Polimorfismo Receptor Esclerosis en placa Citoquina Enfermedad inflamatoria Sistema nervosio central patología Sistema nervioso patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17F Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
- Discipline
- Neurology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1842337
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1212/WNL.52.9.1896 
https://dx.doi.org/10.1212/WNL.52.9.1896
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1212\/WNL.52.9.1896\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:91:\"Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients\";s:9:\"\u0000*\u0000jtitle\";s:9:\"Neurology\";s:9:\"\u0000*\u0000stitle\";s:9:\"Neurology\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"52\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1896\";s:8:\"\u0000*\u0000epage\";s:4:\"1898\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-3878\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SCIACCA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"F. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:8:\"FERRI, C\";i:1;s:13:\"MARTINELLI, V\";i:2;s:7:\"COMI, G\";i:3;s:8:\"CANAL, N\";i:4;s:17:\"GRIMALDI, L. M. E\";i:5;s:15:\"VANDENBROECK, K\";i:6;s:9:\"VEGLIA, F\";i:7;s:8:\"GOBBI, C\";i:8;s:13:\"MARTINELLI, F\";i:9;s:13:\"FRANCIOTTA, D\";i:10;s:12:\"ZAFFARONI, M\";i:11;s:10:\"MARROSU, M\";i:12;s:10:\"MARTINO, G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEURAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:91:\"Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1212\/WNL.52.9.1896\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:91:\"Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients\";s:9:\"\u0000*\u0000jtitle\";s:9:\"Neurology\";s:9:\"\u0000*\u0000stitle\";s:9:\"Neurology\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"52\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1896\";s:8:\"\u0000*\u0000epage\";s:4:\"1898\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-3878\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SCIACCA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"F. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:8:\"FERRI, C\";i:1;s:13:\"MARTINELLI, V\";i:2;s:7:\"COMI, G\";i:3;s:8:\"CANAL, N\";i:4;s:17:\"GRIMALDI, L. M. E\";i:5;s:15:\"VANDENBROECK, K\";i:6;s:9:\"VEGLIA, F\";i:7;s:8:\"GOBBI, C\";i:8;s:13:\"MARTINELLI, F\";i:9;s:13:\"FRANCIOTTA, D\";i:10;s:12:\"ZAFFARONI, M\";i:11;s:10:\"MARROSU, M\";i:12;s:10:\"MARTINO, G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEURAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:91:\"Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1212\/WNL.52.9.1896\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1212\/WNL.52.9.1896\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:91:\"Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients\";s:9:\"\u0000*\u0000jtitle\";s:9:\"Neurology\";s:9:\"\u0000*\u0000stitle\";s:9:\"Neurology\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"52\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1896\";s:8:\"\u0000*\u0000epage\";s:4:\"1898\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-3878\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SCIACCA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"F. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:8:\"FERRI, C\";i:1;s:13:\"MARTINELLI, V\";i:2;s:7:\"COMI, G\";i:3;s:8:\"CANAL, N\";i:4;s:17:\"GRIMALDI, L. M. E\";i:5;s:15:\"VANDENBROECK, K\";i:6;s:9:\"VEGLIA, F\";i:7;s:8:\"GOBBI, C\";i:8;s:13:\"MARTINELLI, F\";i:9;s:13:\"FRANCIOTTA, D\";i:10;s:12:\"ZAFFARONI, M\";i:11;s:10:\"MARROSU, M\";i:12;s:10:\"MARTINO, G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEURAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:91:\"Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1212\/WNL.52.9.1896\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:91:\"Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients\";s:9:\"\u0000*\u0000jtitle\";s:9:\"Neurology\";s:9:\"\u0000*\u0000stitle\";s:9:\"Neurology\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"52\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1896\";s:8:\"\u0000*\u0000epage\";s:4:\"1898\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-3878\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SCIACCA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"F. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:8:\"FERRI, C\";i:1;s:13:\"MARTINELLI, V\";i:2;s:7:\"COMI, G\";i:3;s:8:\"CANAL, N\";i:4;s:17:\"GRIMALDI, L. M. E\";i:5;s:15:\"VANDENBROECK, K\";i:6;s:9:\"VEGLIA, F\";i:7;s:8:\"GOBBI, C\";i:8;s:13:\"MARTINELLI, F\";i:9;s:13:\"FRANCIOTTA, D\";i:10;s:12:\"ZAFFARONI, M\";i:11;s:10:\"MARROSU, M\";i:12;s:10:\"MARTINO, G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEURAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:91:\"Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1212\/WNL.52.9.1896\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:91:\"Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients\";s:9:\"\u0000*\u0000jtitle\";s:9:\"Neurology\";s:9:\"\u0000*\u0000stitle\";s:9:\"Neurology\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"52\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1896\";s:8:\"\u0000*\u0000epage\";s:4:\"1898\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-3878\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SCIACCA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"F. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:8:\"FERRI, C\";i:1;s:13:\"MARTINELLI, V\";i:2;s:7:\"COMI, G\";i:3;s:8:\"CANAL, N\";i:4;s:17:\"GRIMALDI, L. M. E\";i:5;s:15:\"VANDENBROECK, K\";i:6;s:9:\"VEGLIA, F\";i:7;s:8:\"GOBBI, C\";i:8;s:13:\"MARTINELLI, F\";i:9;s:13:\"FRANCIOTTA, D\";i:10;s:12:\"ZAFFARONI, M\";i:11;s:10:\"MARROSU, M\";i:12;s:10:\"MARTINO, G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEURAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:91:\"Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
